Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Teicher

Showing results (81-90 of 417) with videos related to

Pageof 42
Sort By:
Cancer Treatment and Research Communications|October 3, 2021
Format (2D vs 3D) and media effect target expression and response of patient-derived and standard NSCLC lines to EGFR inhibitorsGurmeet Kaur, James H Doroshow, Beverly A Teicher
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1992
Enhancement of fractionated radiation therapy by an experimental concentrated perflubron emulsion (Oxygent) in the Lewis lung carcinomaB A Teicher, T S Herman, K Menon
British Journal of Cancer|May 1, 1989
Platinum-dye complexes inhibit repair of potentially lethal damage following bleomycin treatmentY Wang, T S Herman, B A Teicher
International Journal of Radiation Oncology, Biology, Physics|May 1, 1985
Radiosensitization of EMT6 cells by four platinum complexesB A Teicher, S Rockwell, J B Lee
Angiology|February 1, 1980
Minoxidil in the treatment of refractory hypertensionT Rosenthal, J Swartz, A Teicher, et al.
Cell Cycle (Georgetown, Tex.)|February 21, 2014
Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitorsSameer H Issaq, Beverly A Teicher, Anne Monks
Angiology|March 1, 1980
Minoxidil in the treatment of refractory hypertensionT Rosenthal, J Swartz, A Teicher, et al.
Cancer Letters|December 9, 1994
Long-term persistence and cytokinetics of human tumor cells in vitro following high-dose alkylating agent exposureS A Holden, B A Teicher, E Frei
Cancer Letters|October 14, 1994
SR-4233 (Tirapazamine) acts as an uncoupler of oxidative phosphorylation in human MCF-7 breast carcinoma cellsG Ara, C N Coleman, B A Teicher
Harefuah|December 15, 1978
[Combined clonidine-chlorthalidone therapy of hypertension]E Kissin, A Teicher, N Stern, et al.
Pageof 42

Showing results (81-90 of 417) with videos related to

Sort By:
Pageof 42
Cancer Treatment and Research Communications|October 3, 2021
Format (2D vs 3D) and media effect target expression and response of patient-derived and standard NSCLC lines to EGFR inhibitorsGurmeet Kaur, James H Doroshow, Beverly A Teicher
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1992
Enhancement of fractionated radiation therapy by an experimental concentrated perflubron emulsion (Oxygent) in the Lewis lung carcinomaB A Teicher, T S Herman, K Menon
British Journal of Cancer|May 1, 1989
Platinum-dye complexes inhibit repair of potentially lethal damage following bleomycin treatmentY Wang, T S Herman, B A Teicher
International Journal of Radiation Oncology, Biology, Physics|May 1, 1985
Radiosensitization of EMT6 cells by four platinum complexesB A Teicher, S Rockwell, J B Lee
Angiology|February 1, 1980
Minoxidil in the treatment of refractory hypertensionT Rosenthal, J Swartz, A Teicher, et al.
Cell Cycle (Georgetown, Tex.)|February 21, 2014
Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitorsSameer H Issaq, Beverly A Teicher, Anne Monks
Angiology|March 1, 1980
Minoxidil in the treatment of refractory hypertensionT Rosenthal, J Swartz, A Teicher, et al.
Cancer Letters|December 9, 1994
Long-term persistence and cytokinetics of human tumor cells in vitro following high-dose alkylating agent exposureS A Holden, B A Teicher, E Frei
Cancer Letters|October 14, 1994
SR-4233 (Tirapazamine) acts as an uncoupler of oxidative phosphorylation in human MCF-7 breast carcinoma cellsG Ara, C N Coleman, B A Teicher
Harefuah|December 15, 1978
[Combined clonidine-chlorthalidone therapy of hypertension]E Kissin, A Teicher, N Stern, et al.
Pageof 42